Oncology Banner

In oncology research, progress rarely comes from resolutions, but from persistence, precision and the right tools at the right moment. At Tebubio, we start this new year with the same focus that drives your work at the bench: enabling robust experiments, reproducible data and informed choices in an increasingly complex research landscape.

Published Articles

Find an alternative to animal models

Have a look at this article published in the Technology Networks and get insights into how in vitro oncology models are transforming cancer research by offering a reliable alternative to traditional animal models.

 

Product Highlights

PROTACs, molecular glues & beyond

LifeSensors provides cutting-edge tools for targeted protein degradation research, from discovery to mechanistic insights.

Read more ➔

iPSC models from diseased donors

Enable functional studies from mutations to phenotypes with Reproducible human iPSC models.

Read more ➔

STED & SIM super-resolution imaging dyes

Access ultra-stable, bright stains, available in a wide range of colours for lysosomes, membranes, cytoskeleton, and more.

Read more ➔

Recorded Webinar

From interferon and cytokines to innovation

In this session, Dr. Alok Pandey discusses key scientific considerations for reliable cytokine measurement and evaluating assay performance in disease-state versus healthy matrices.

 


Recorded Webinars

[Case Study] Tracking tools for mRNA research

  • mRNA production

  • LNP formulation

  • 3D models

  • Q&A session with project managers

Watch this webinar ➔

Development of TCR-T and CAR-T cells

  • New suite of tools supporting CAR-T and TCR-T cell R&D

  • Primary human immune cells

 

 Watch this webinar ➔

In vivo drug delivery with Certest lipids

  • Advanced strategies

  • Certest Pharma’s proprietary lipids

  • Technology adaptation

 

Watch this webinar ➔

Stay Ahead in Your Research

Subscribe to our monthly newsletter for the latest breakthroughs, expert insights, and exclusive updates in key research areas.